UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$234M |
| 2 |
Home Depot
HD
|
+$214M |
| 3 |
Intercontinental Exchange
ICE
|
+$206M |
| 4 |
TJX Companies
TJX
|
+$129M |
| 5 |
BorgWarner
BWA
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$227M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$212M |
| 3 |
Mohawk Industries
MHK
|
+$137M |
| 4 |
Liberty Global Class A
LBTYA
|
+$114M |
| 5 |
Freeport-McMoran
FCX
|
+$112M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.05% |
| 2 | Technology | 13.96% |
| 3 | Financials | 13.95% |
| 4 | Industrials | 9.13% |
| 5 | Energy | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Groupon
GRPN
$1.04B
| $1.65M | ﹤0.01% |
12,440
| – | – |
|
|
VTLE
1352
DELISTED
Vital Energy
VTLE
| $1.65M | ﹤0.01% |
2,655
+842
| +46% | +$477K |
|
1353
Carpenter Technology
CRS
$28.3B
| $1.64M | ﹤0.01% |
25,980
+600
| +2% | +$38.1K |
|
|
SGY
1354
DELISTED
Stone Energy
SGY
| $1.64M | ﹤0.01% |
618
+122
| +25% | +$308K |
|
|
PNY
1355
DELISTED
PIEDMONT NATURAL GAS CO INC(NC
PNY
| $1.64M | ﹤0.01% |
43,798
| – | – |
|
1356
First Horizon
FHN
$12.4B
| $1.62M | ﹤0.01% |
136,901
| – | – |
|
1357
Generac Holdings
GNRC
$12.8B
| $1.62M | ﹤0.01% |
33,198
+3,500
| +12% | +$184K |
|
|
MCP
1358
DELISTED
MOLYCORP INC COM STK
MCP
| $1.62M | ﹤0.01% |
629,013
+227,183
| +57% | +$821K |
|
1359
Luxfer Holdings
LXFR
$458M
| $1.62M | ﹤0.01% |
85,276
-604
| -0.7% | -$11.6K |
|
1360
Curtiss-Wright
CW
$27.6B
| $1.61M | ﹤0.01% |
24,591
+500
| +2% | +$32.8K |
|
1361
First American
FAF
$7.66B
| $1.61M | ﹤0.01% |
57,997
+200
| +0.3% | +$5.45K |
|
1362
Sensient Technologies
SXT
$5.54B
| $1.61M | ﹤0.01% |
28,898
| – | – |
|
|
TECD
1363
DELISTED
Tech Data Corp
TECD
| $1.61M | ﹤0.01% |
25,710
| – | – |
|
1364
Advanced Micro Devices
AMD
$786B
| $1.6M | ﹤0.01% |
383,032
| – | – |
|
1365
Hancock Whitney
HWC
$6.3B
| $1.6M | ﹤0.01% |
45,362
+600
| +1% | +$20.7K |
|
|
BYI
1366
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $1.6M | ﹤0.01% |
24,307
+900
| +4% | +$56.2K |
|
1367
Portland General Electric
POR
$5.79B
| $1.59M | ﹤0.01% |
45,998
+4,500
| +11% | +$148K |
|
|
LGF
1368
DELISTED
Lions Gate Entertainment
LGF
| $1.59M | ﹤0.01% |
55,643
+500
| +0.9% | +$13.5K |
|
|
SD
1369
DELISTED
SANDRIDGE ENERGY, INC.
SD
| $1.58M | ﹤0.01% |
221,655
| – | – |
|
|
AAT
1370
American Assets Trust
AAT
$1.42B
| $1.58M | ﹤0.01% |
45,819
+3,020
| +7% | +$103K |
|
1371
John Wiley & Sons Class A
WLY
$2.76B
| $1.58M | ﹤0.01% |
26,025
| – | – |
|
1372
Hanmi Financial
HAFC
$961M
| $1.57M | ﹤0.01% |
74,332
-61,600
| -45% | -$1.35M |
|
|
PRA
1373
DELISTED
ProAssurance
PRA
| $1.55M | ﹤0.01% |
35,010
| – | – |
|
1374
Graphic Packaging
GPK
$3.52B
| $1.55M | ﹤0.01% |
132,193
+6,000
| +5% | +$64.3K |
|
1375
STAG Industrial
STAG
$7.19B
| $1.54M | ﹤0.01% |
64,290
+10,000
| +18% | +$239K |
|
Similar funds
UBS AM's Q2 2014 Portfolio in Review
As of Q2 2014, UBS AM held 2,651 positions worth $99B, up 5.7% from $93.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2014 filing shows 81 new, 1,135 increased, 556 reduced and 97 closed positions. Its largest new stake was Sabre: 3,529,400 shares worth $70.8M. The largest sale was Allergan Inc, an estimated $227M.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q2 2014 buy was Sabre: 3,529,400 shares worth $70.8M.
- UBS AM added most to Thermo Fisher Scientific in Q2 2014, an estimated $234M increase.
- UBS AM's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $227M.
- UBS AM fully exited Freeport-McMoran in Q2 2014, selling an estimated $112M.
- UBS AM's ten largest holdings make up 14% of its $99B portfolio in Q2 2014.
- UBS AM opened 81 new positions and closed 97 in Q2 2014.
- UBS AM's portfolio value rose 5.7% quarter-over-quarter to $99B.
Based on UBS AM's 13F filing for Q2 2014, filed 13 Aug 2014.